Dyadic International DYAI
NASDAQ DYAI
$0.69 -0.01 (-1.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Dyadic International (DYAI) Cash from Operations (2018 - 2026)

Dyadic International (DYAI) posted Cash from Operations of 1963334.0 for Q1 2026, down 10.92% sequentially from 1770111.0 in Q4 2025, and down 0.7% YoY from 1977128.15 in Q1 2025.

Dyadic International (DYAI) Cash from Operations (2018 - 2026) Analysis & Trends

Dyadic International has reported Cash from Operations for 9 years, with the latest figure at 1963334.0 in Q1 2026.

  • Quarterly Cash from Operations fell 0.7% year-over-year to 1963334.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5715824.0 (down 18.79% YoY) and the FY2025 annual result came in at 5702221.0, down 43.46% from the prior year.
  • Cash from Operations declined to 1963334.0 in Q1 2026 per DYAI's latest filing, from 1770111.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 130015.0 in Q2 2025 and troughed at 2850383.0 in Q1 2022.
  • A 5-year average of 1555934.76 and a median of 1775417.0 in 2022 frame the typical range for Cash from Operations.
  • The sharpest annual moves came in 2022 and 2025: Cash from Operations surged 99.85% in 2022, then slumped 821.31% in 2025.
  • Over 5 years, Cash from Operations stood at 1681762.0 in 2022, then soared by 45.09% to 923380.0 in 2023, then gained by 24.58% to 696395.0 in 2024, then tumbled by 154.18% to 1770111.0 in 2025, then declined by 10.92% to 1963334.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered 1963334.0, 1770111.0, and 1852364.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.13 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 813.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -526.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 462.82 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 326.72 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 360.27 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -88.83 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 728.46 Mn
10 Dyadic International 19.98 Mn 19.98 Mn - -1.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.96 Mn
Mar 31, 2026 -1.96 Mn
Dec 31, 2025 -1.77 Mn
Dec 31, 2025 -1.77 Mn
Sep 30, 2025 -1.85 Mn
Sep 30, 2025 -1.85 Mn
Jun 30, 2025 -130,015.00
Jun 30, 2025 -130,015.00
Mar 31, 2025 -1.95 Mn
Mar 31, 2025 -1.95 Mn
Dec 31, 2024 -696,395.00
Dec 31, 2024 -696,395.00
Sep 30, 2024 -201,057.00
Sep 30, 2024 -201,057.00
Jun 30, 2024 -1.96 Mn
Jun 30, 2024 -1.96 Mn
Mar 31, 2024 -1.11 Mn
Mar 31, 2024 -1.11 Mn
Dec 31, 2023 -923,380.00
Dec 31, 2023 -923,380.00